Zephyr AI uses large complex data and proprietary algorithms to discover new insights and opportunities for Personalized/Precision Medicine, Drug Discovery, Drug Rescue, and Clinical Decision Support. Zephyr AI partners with leading health systems, health insurance plans, and biotechnology pioneers to improve Quality, Outcomes, and Costs. The Zephyr Flywheel: incredible people create groundbreaking algorithms yielding unprecedented insights. This attracts world-class partners, allowing us to build the most comprehensive dataset in the world, which attracts incredible people.

Our platform aligns incentives across Pharma, Payers, and Providers to optimize patient outcomes in Oncology and Cardiometabolic Disease. Our machine learning algorithms stand at the forefront of research and development in the field, harnessing recent breakthroughs, particularly in representation learning. Among these advancements, our Vulnerability Network™ catalog serves as a key set of representations, enabling the identification of unforeseen responders to cancer drugs. Beyond their biological interpretability, Vulnerability Networks™ have demonstrated efficacy in target discovery and rational drug combination design. Our algorithms facilitate the use of real-world data for retrospective validation and prospective evaluation in clinical settings.